The global burden of SLE: prevalence, health disparities and socioeconomic impact

EE Carter, SG Barr, AE Clarke - Nature reviews rheumatology, 2016 - nature.com
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that can
potentially lead to serious organ complications and even death. Its global burden—in terms …

Damage in systemic lupus erythematosus and its association with corticosteroids

A Zonana‐Nacach, SG Barr… - Arthritis & Rheumatism …, 2000 - Wiley Online Library
Objective To evaluate the association between corticosteroid use and organ damage in
patients with systemic lupus erythematosus (SLE). Methods The occurrence and date of …

Patterns of disease activity in systemic lupus erythematosus

SG Barr, A Zonana‐Nacach… - Arthritis & Rheumatism …, 1999 - Wiley Online Library
Objective To describe patterns of systemic lupus (SLE) disease activity over time. Methods
Disease activity was measured in a prospective cohort of 204 consecutive SLE patients …

A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus

A Ho, SG Barr, LS Magder, M Petri - Arthritis & Rheumatism, 2001 - Wiley Online Library
Objective To determine the degree to which changes in C3 and C4 precede or coincide with
changes in systemic lupus erythematosus (SLE) activity, as measured by 5 global activity …

Decreases in anti–double‐stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus

A Ho, LS Magder, SG Barr, M Petri - Arthritis & Rheumatism, 2001 - Wiley Online Library
Objective To determine the degree to which changes in anti–double‐stranded DNA (anti‐
dsDNA), as determined by Crithidia and enzyme‐linked immunosorbent assays (ELISAs) …

Lymphoma risk in systemic lupus: effects of disease activity versus treatment

S Bernatsky, R Ramsey-Goldman, L Joseph… - Annals of the …, 2014 - ard.bmj.com
Objective To examine disease activity versus treatment as lymphoma risk factors in systemic
lupus erythematosus (SLE). Methods We performed case–cohort analyses within a multisite …

[HTML][HTML] The use and abuse of commercial kits used to detect autoantibodies

MJ Fritzler, A Wiik, ML Fritzler, SG Barr - Arthritis Res Ther, 2003 - Springer
The detection of autoantibodies in human sera is an important approach to the diagnosis
and management of patients with autoimmune conditions. To meet market demands …

[HTML][HTML] Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies

C Fitch-Rogalsky, W Steber, M Mahler, T Lupton… - PloS one, 2014 - journals.plos.org
Background The referral of patients with positive anti-nuclear antibody (ANA) tests has been
criticized as an inappropriate use of medical resources. The utility of a positive ANA test in a …

Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada

C Barnabe, L Joseph, P Belisle… - Arthritis care & …, 2012 - Wiley Online Library
Objective To estimate the population‐based prevalence of systemic lupus erythematosus
(SLE) and systemic sclerosis (SSc) in Alberta, Canada, stratified by First Nations status …

Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.

LM Luft, SG Barr, LO Martin, EKL Chan… - The Journal of …, 2003 - jrheum.org
OBJECTIVE: Sjögren's syndrome (SS) has been reported in up to 15% of patients with
biopsy proven celiac disease (CD). The diagnosis of CD in the setting of SS and other …